Phenyl sulfone-containing 2, 3-diarylindole derivatives were designed and identified to be selective COX-2 inhibitors. A convenient synthetic route was also developed for the synthesis of the novel inhibitors.
Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on l...Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.展开更多
目的系统评价选择性环氧合酶2(COX-2)抑制剂用于人工全髋/膝关节置换术(THA/TKA)超前镇痛的效果与安全性,为临床用药提供循证参考。方法计算机检索中国知网、维普网、中国生物医学文献服务系统、万方数据、PubMed、Embase、Scopus、Web ...目的系统评价选择性环氧合酶2(COX-2)抑制剂用于人工全髋/膝关节置换术(THA/TKA)超前镇痛的效果与安全性,为临床用药提供循证参考。方法计算机检索中国知网、维普网、中国生物医学文献服务系统、万方数据、PubMed、Embase、Scopus、Web of Science和Cochrane图书馆,收集选择性COX-2抑制剂用于THA/TKA超前镇痛联合术后镇痛(试验组)对比单纯术后镇痛(对照组)的随机对照试验(RCT),检索时间均为建库起至2022年2月15日。筛选文献、提取资料后采用Cochrane系统评价员手册5.1.0推荐的RCT偏倚风险评估工具对纳入文献进行质量评价,采用RevMan 5.3软件进行Meta分析。结果共纳入6项RCT,合计916例患者。与对照组比较,试验组患者术后的静息状态下[MD=-0.20,95%CI(-0.30,-0.10),P<0.0001]和活动状态下[MD=-0.20,95%CI(-0.27,-0.13),P<0.00001]的疼痛视觉模拟法评分、患者自控镇痛(PCA)药物总消耗量[MD=-5.89,95%CI(-8.98,-2.80),P=0.0002]、术后恶心呕吐发生率[RR=0.79,95%CI(0.65,0.95),P=0.01]均显著低于对照组。结论选择性COX-2抑制剂超前镇痛联合术后镇痛,较单纯术后镇痛可明显减轻THA/TKA患者术后早期疼痛,减少PCA药物总消耗量,降低术后恶心呕吐发生率。展开更多
基金support for this study was provided by the National Natural Science foundation of China.
文摘Phenyl sulfone-containing 2, 3-diarylindole derivatives were designed and identified to be selective COX-2 inhibitors. A convenient synthetic route was also developed for the synthesis of the novel inhibitors.
文摘Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.
文摘目的系统评价选择性环氧合酶2(COX-2)抑制剂用于人工全髋/膝关节置换术(THA/TKA)超前镇痛的效果与安全性,为临床用药提供循证参考。方法计算机检索中国知网、维普网、中国生物医学文献服务系统、万方数据、PubMed、Embase、Scopus、Web of Science和Cochrane图书馆,收集选择性COX-2抑制剂用于THA/TKA超前镇痛联合术后镇痛(试验组)对比单纯术后镇痛(对照组)的随机对照试验(RCT),检索时间均为建库起至2022年2月15日。筛选文献、提取资料后采用Cochrane系统评价员手册5.1.0推荐的RCT偏倚风险评估工具对纳入文献进行质量评价,采用RevMan 5.3软件进行Meta分析。结果共纳入6项RCT,合计916例患者。与对照组比较,试验组患者术后的静息状态下[MD=-0.20,95%CI(-0.30,-0.10),P<0.0001]和活动状态下[MD=-0.20,95%CI(-0.27,-0.13),P<0.00001]的疼痛视觉模拟法评分、患者自控镇痛(PCA)药物总消耗量[MD=-5.89,95%CI(-8.98,-2.80),P=0.0002]、术后恶心呕吐发生率[RR=0.79,95%CI(0.65,0.95),P=0.01]均显著低于对照组。结论选择性COX-2抑制剂超前镇痛联合术后镇痛,较单纯术后镇痛可明显减轻THA/TKA患者术后早期疼痛,减少PCA药物总消耗量,降低术后恶心呕吐发生率。
